Results 181 to 190 of about 25,585 (256)

Neoadjuvant chemotherapy and bevacizumab for colorectal peritoneal metastases: clinical and translational outcomes of the phase II BEV-IP trial. [PDF]

Transl Oncol
Chia DKA, Demuytere J, Hoorens A, De Meuleneir K, Cosyns S, Van der Speeten K, Liberale G, Vansteenkiste F, Willaert W, Ceelen W.   +9 more
europepmc   +1 more source

Real-world outcomes and prognostic factors of trifluridine/tipiracil plus bevacizumab in metastatic colorectal cancer: a multicenter study in Spain. [PDF]

ESMO Gastrointest Oncol
Martínez-Lago N, Reboredo López M, Riesco Martínez MC, López Peraita S, González Gómez B, Antonilli Pérez C, Ghanem I, Pérez Martelo M, López Alfonso A, Fernández Montes A, Agraso Busto S, Jiménez Gordo AM, Melian Sosa M, Gallardo Martín E, Cabezón-Gutiérrez L, Cousillas Castiñeiras A, LLanos Muñoz M, Ochoa Rivas MP, Gutiérrez Abad D, de la Cámara Gómez J, De Frutos González B, López Muñoz AM, Ferreiro Monteagudo R.   +22 more
europepmc   +1 more source

Baseline DCP May Modify Response to Atezolizumab-Bevacizumab Versus Durvalumab-Tremelimumab in Unresectable HCC. [PDF]

Liver Int
Tanaka K, Tsuji K, Hiraoka A, Tada T, Hirooka M, Kariyama K, Tani J, Atsukawa M, Takaguchi K, Itobayashi E, Nishimura T, Ishikawa T, Tajiri K, Tanaka H, Toyoda H, Ogawa C, Hatanaka T, Kakizaki S, Kawata K, Naganuma A, Kosaka H, Matono T, Ueda Y, Kuroda H, Yata Y, Nishikawa H, Imai M, Aoki T, Ochi H, Okamura J, Tamai H, Nakamura S, Nakamura Y, Yoshida O, Nouso K, Morishita A, Itokawa N, Okubo T, Arai T, Tsutsui A, Nagano T, Tada F, Ohama H, Koshiyama Y, Kanayama Y, Noritake H, Komatsu S, Fukumoto T, Matsuura T, Kim SK, Enomoto H, Matsui K, Kaibori M, Hiasa Y, Kudo M, Kumada T, Real‐life Practice Experts for HCC (RELPEC) Study Group and hepatocellular carcinoma experts from 48 clinics in Japan (HCC 48) Group.   +56 more
europepmc   +1 more source

Detection and molecular characterization of bovine enterovirus E2 from dairy calves with respiratory disease in Urumqi, Xinjiang, China. [PDF]

Front Cell Infect Microbiol
Chen X, Pan J, Wang Y, Wei Y, Zhang X, Jiang H, Zhang L, Wu G, Chen B, Xie J, Tong P.   +10 more
europepmc   +1 more source

Spatially-Aware Reliability Modeling for BEV LiDAR 3D Vehicle Detection. [PDF]

Sensors (Basel)
Hu N, Zhang Z, Wu D, Dadashova B, Winata F, Filippi AM.   +5 more
europepmc   +1 more source

Bacterial extracellular vesicles and direct microbial contact drive species-specific corneal epithelial reprogramming. [PDF]

Front Cell Infect Microbiol
Blanco-Agudín N, Ye S, González-Fernández S, Fernández-Vega I, Merayo-Lloves J, Quirós LM.   +5 more
europepmc   +1 more source

Comparative Effectiveness and Safety of Atezolizumab-Bevacizumab and Durvalumab-Tremelimumab as First-Line Systemic Therapy for Hepatocellular Carcinoma: A Real-World Study. [PDF]

J Gastroenterol Hepatol
Lin SH, Wu JL, Tsai YN, Tseng CH, Chen PY, Hsu YC.   +5 more
europepmc   +1 more source

Bacterial Extracellular Vesicles as Regulators of the Gut Microbiome-Circadian Axis in Inflammatory and Metabolic Diseases. [PDF]

J Microbiol Biotechnol
Choi H, Oh S, Kim Y.
europepmc   +1 more source

Beyond side effects: treatment-related adverse events are associated with improved survival outcomes in HCC patients on atezolizumab-bevacizumab therapy. [PDF]

BMC Cancer
Xu XQ, Li WM, Shi LC, Wang H, Li S, Huang C, You H, Jia JD, He YW, Kong YY.   +9 more
europepmc   +1 more source

Feasibility and Outcomes of Percutaneous Coronary Intervention After TAVI: A Comparison Between BEV and SEV Platforms. [PDF]

J Clin Med
Arow Z, Oliva O, Iwata J, Masumoto A, Clement A, Zuccarelli V, Millin A, Assali A, Dumonteil N, Tchetche D, De Biase C.   +10 more
europepmc   +1 more source